Sanara MedTech (SMTI) Net Equity Issued and Repurchased (2010 - 2021)

Sanara MedTech (SMTI) posted Net Equity Issued and Repurchased of $28.9 million for Q1 2021, up 57720.69% on a QoQ basis from $50050.0 in Q1 2017.

Sanara MedTech (SMTI) Net Equity Issued and Repurchased (2010 - 2021) Analysis & Trends

Sanara MedTech's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $28.9 million for Q1 2021.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $28.9 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $28.9 million (changed N/A YoY) and the FY2012 annual result came in at $100000.0, down 89.58% from the prior year.
Net Equity Issued and Repurchased was $28.9 million for Q1 2021 at Sanara MedTech, up from $50050.0 in the prior quarter.
Across five years, Net Equity Issued and Repurchased topped out at $28.9 million in Q1 2021 and bottomed at $50050.0 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	7.43 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	11.72 Mn
10	Sanara MedTech	233.71 Mn	220.11 Mn	25.87 Mn	-

Download Data